Get started
BIONTECH SE DRNBIONTECH SE DRNBIONTECH SE DRN

BIONTECH SE DRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

B1NT34 trade ideas

Where is this going to stop ?For now the covid stocks remain bearish but i don't think that the long term bullish trend is over, so we will play the way the chart tells us too. Here is my trading plan - Next week, we should see a minor sideways uptrend towards $241 or a bit above that. The choppy nature followed by a minor impulse during the Earnings (expect to for a bear flag or a triangle pattern) will confirm the wave iv. Once it breaks the pattern formed, we are going to take the short for the target of $185. - Post that we will see if the Bull tries to fight and start an impulse up or this goes sideways for few weeks.
NASDAQ:BNTXShort
by rbswingtrader
potential bull run to the Q3 earningsThe news are great, the fundamentals better than ever, but the stock is dropping. WHY? The big reason is, that big money wants to buy your share before the next bull run. Therefore they try to push the price into liquidity zones where a lot of Stop/Losses are triggered. 250€ and 200€ are important Fibonacci targets which act like magnets. Bull Case: These are the current support zones. If we assume that we have a finished Elliott Wave, than 250€ could be a support with the 0.618 Fibonacci Retracment. This is the current Elliott Wave count, eventhough it's not quite perfect. Ignoring some minor flaws, it's still intact. If we do a normal extention than we could have a first target nearby 600€ (700$) and 800€ (903$) for the long term. (bear in mind that there could be an overthrow due to the hype in a parabolic movement) Are 600€ even possible? Fundamentally, Yes. Technically, Yes. We had a 144% gain on the last run to the Q2 earnings which we need now for a 600€ target. What are the risk? If the Elliott Wave isn't correct, than we could drop even further to the bigger correction nearby 200€. The current sentiment is extremely cautious due to the Evergrand situation. It's all about timing now if we hit the perfekt window. PS: I'm just drawing lines. These charts are extremely speculativ. Do your own due dilligence!
FWB:22UALong
by MuffyPuffy
11
BNTX Daily TimeframeSNIPER STRATEGY This magical strategy works like a clock on almost any charts Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading. It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave. The best timeframe for this strategy is Daily, Weekly and Monthly however it can work any timeframe above three minutes. Start believing in this strategy because it will reward believers with huge profit. There is a lot more about this strategy. It can predict and also it can give you almost exact buy or sell time on the spot. I am developing it even more so stay tuned and start to follow me for more signals and forecasts.
NASDAQ:BNTXShort
by hadimozayan
BNTX - HTF Candidate w/ R/R Favorability - (9/12/2021)MA have caught up in this name which offers a good entry point that is not overextended. Stock has made 2 100% run ups after a consolidation pattern. If we look at volume in the last run up there was more volume than the previous run which indicates inst. support. Will manage risk at the lows of Thursday which is about a 3.7% risk where the upside potential is the previous peak or 31%. ATR is also declining which is a positive signal. Market breath overall is worsening which makes me cautious moving into next week. Will have tight risk through next week and be taking minimal new positions until the market tells me we are back in a uptrend.
NASDAQ:BNTXLong
by huntersanna33
BNTX ShortNASDAQ:BNTX Hey guys, This is my first analysis so please do not be too harsh on me. After several months of exceptional performance, I do believe that the Biontech stock reached its peak on 10-08-2021 (450$). The vaccinations are still going on and a lot of people opt for the Fizer/Biontech vaccine with certainly has its impact on the stock market. I have little to no experience in Fundamentals, so I choose the technical path. Looking at the Chart (4H Timeframe) you can see with the Ichimoku cloud (settings: 20, 60, 120, 30), RSI (14), DMI (14, 14), and the Volume that the upwards trend is slowly starting to subside. Even without indicators, this fade is pretty obvious. Looking at the Ichimoku cloud the price broke the cloud and seems to move down. This theory is supported by the fact that a crossing between the Conversion Line and the Base Line. The DMI Indicator saw this trend reversal a week earlier so this is also a confirmation sign. Furthermore, we can observe that the RSI broke below the "50" line and is moving dangerously close to the oversold section. Now since this is still an upwards trend, with the price still above the 200 MA with addition to trend lines, it is difficult to say if this move right now is a trend reversal or just a correction for the overbought timespan end Juli till mid-August. Taking in the Fib-Retracements into account for this setup the most likely scenario would be that the price retests the Ichimoku cloud and moves to the 0.618 retracement. So the setup would be: Entry: 324€ Stop loss: 330€ (above the Leading Span B/ red line from the cloud but below the green line Span A) Take profit: 301€ (above 300€ natural horizontal support/resistance) Hope this analysis helps you with the decision :) Happy trading Ocamond
NASDAQ:BNTXShort
by Ocamond
looking for sell #BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Covid-19 vaccine maker BioNTech plans to make any malaria or tuberculosis vaccine it develops in Africa, the company said on Friday. The announcement comes at a time when debate is growing over the moral obligation of richer countries to share Covid-19 vaccines with poorer ones—particularly the messenger RNA-based vaccines developed by BioNTech (ticker: BNTX), its partner, Pfizer (PFE), and their competitor, Moderna
NASDAQ:BNTXShort
by IM-Forex